Skip to content
Prepare your lab for the DENGUE emergency with Seegene

Discover the Seegene’s Novaplex Tropical Fever Virus test!

Making Molecular Testing More Accessible

Seegene USA is a leading developer of multiplex molecular assays and automated solutions for US labs. Seegene aims to support a healthy life for everyone by creating a new testing paradigm.

One Sample,
Many Answers

Seegene’s solutions offer user friendly workflows for the laboratories and comprehensive molecular PCR results that enable fact-based research. Our technology makes it possible to detect hundreds of targets on a single platform.

Upcoming Webinar

Apr 10, 9:00 PM – 10:00 PM



Learning Objectives

  • Describe the common etiologies of sexually transmitted infections (STIs) and their symptoms.
  • Discuss historic and current epidemiologic STI Trends. Understand the treatment options for patients diagnosed with STIs.
  • List laboratory test methods used to detect STIs and resistance markers.
Upcoming Event

May 6-9, 2024



The APHL 2024 Annual Conference will be held May 6-9, 2024, in Milwaukee, WI.

The APHL 2024 Annual Conference

Infectious Diseases

Learn more about all the assays we offer—search by disease type below.

Infectious Diseases
High Multiplex PCR Products

Seegene provides molecular PCR products capable of detecting multiple targets simultaneously. Our high multiplex assays deliver comprehensive information using our proprietary technology that produces high multiplex results from a single channel in a PCR reaction.

Detect CT, NG, TV, MG, and more STIs with confidence

Cover all your lab’s respiratory needs

Detection and identification of 18 targets

Molecular solutions for GI bacteria, viruses, and parasites

Learn more about Seegene’s high multiplex real-time PCR technologies

A highlight of our latest news, press & blog

Sexually Transmitted Infections in the US

Each year there are about 20 million new cases of sexually transmitted infections (STIs) in the United States. More than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported…

Seegene Announces Collaboration with Microsoft to Realize ‘a World Free from All Diseases’

Press Release For immediate release Seegene Announces Collaboration with Microsoft to Realize ‘a World Free from All Diseases’ Strategic collaboration to open a new chapter in the field of molecular…

Seegene USA, Inc. Announces Collaboration with Microbix Biosystems Inc.

Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy Expanded Collaboration to Improve Syndromic Infectious Disease Testing IRVINE, CA, USA, December 14, 2023 / — Seegene USA, Inc. (“Seegene USA”),…

Comprehensive testing for major respiratory viruses and bacteria

Respiratory infections are a common health concern that affects individuals across all age groups. These infections, which range from the common cold and flu to more severe respiratory illnesses, can…

Doctor takes a multiplex PCR test sample from a young girl

Long before SARS-CoV-2 turned the world upside down, severe acute respiratory disease was already a major cause of morbidity and mortality for adults and children all over the world. As…

SGHQ Open Innovation Program

Together, we can create a disease-free future Register for the webcast – A replay will be available for those who register! Click ▶ Nature Research ( Date: Thursday, September 21,…

Back To Top